Drug Approval | April 12, 2023
Zydus receives final approval from USFDA for Tavaborole Topical Solution
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Women of all ages will get round-the-clock access to comprehensive treatment
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Subscribe To Our Newsletter & Stay Updated
